News

WuXi AppTec Launches NMR-Based FBDD Platform for Drug Discovery

WuXi AppTec introduces a customizable NMR-based fragment screening platform with 4K+ fragment library, orthogonal validation methods, and SAR-driven structural modeling to accelerate drug design.

15 August 2025 | Product Launch

British Scientists Create Syn57: E. coli with Radically Recoded Genome

Researchers at MRC Laboratory of Molecular Biology engineered Syn57 with only 57 codons after 100,000 DNA edits, unlocking potential for novel amino acids and virus-resistant bacteria.

13 August 2025 | Technology Development

WashU Receives $5.2M for Advanced Biomanufacturing Research

Washington University researchers, led by Prof. Fuzhong Zhang, will develop a genetic “switch” enabling microbes to sustain high-efficiency continuous fermentation, funded with up to $5.2 million from DARPA.

13 August 2025 | Investment

Colorcon Ventures Invests in Phytolon to Advance Natural Colors via Precision Fermentation

Phytolon receives strategic investment to commercialize natural, high-performing colors via precision fermentation, aligning with Colorcon’s commitment to innovation and sustainable solutions.

13 August 2025 | Investment

REACH and Samsara Eco Launch Enzyme-Powered Textile Recycling

REACH and Samsara Eco develop a world-first enzymatic recycling technology capable of converting synthetic fibers like nylon 6,6 and PET into virgin-quality materials, addressing centuries-old textile waste.

12 August 2025 | Collaboration

Neogen Forms Partnership with Biomatter to Advance Enzyme Innovation

Neogen has entered into a collaboration with Biomatter to leverage AI-driven enzyme design for developing advanced food safety solutions, aiming to enhance detection and improve global food quality.

11 August 2025 | Collaboration

ProBio Launches cGMP AAV Manufacturing in New Hopewell Facility

ProBio has opened a 128,000 sq. ft. Hopewell, NJ facility offering integrated cGMP AAV manufacturing, including plasmid DNA, vector production, fill/finish, and in-house analytics to accelerate gene therapy development.

11 August 2025 | Manufacturing

Almirall Expands AI Drug Discovery Collaboration with Absci

Almirall has selected a second dermatology target in its partnership with Absci, following the successful design of functional antibody leads. The expanded collaboration aims to accelerate the development of AI-designed therapeutics for chronic skin conditions.

07 August 2025 | Collaboration

Industry leaders use Knowledge Hub to explore 740+ Synthetic Biology news

Gain unparalleled insights, and drive your innovation forward.

Let’s shape tomorrow, today!